期刊文献+

SARS冠状病毒核衣壳蛋白的克隆表达及其临床应用研究 被引量:1

Molecular cloning and expression of the severe acute respiratory syndrome-associated coronavirus nucleocapsid protein and its clinical application
原文传递
导出
摘要 目的 克隆、原核表达严重急性呼吸综合征冠状病毒 (SARS-CoV)核衣壳 (N)蛋白 ,分析、评价其抗原性和在SARS血清学诊断中的应用价值。方法 采用逆转录巢式聚合酶链反应 (RT-nested PCR)扩增SARS CoV的N蛋白基因 ,克隆入pBAD-Thio TOPO原核表达载体 ,表达、纯化重组融合N蛋白 ,WesternBlot分析其抗原性和特异性 ,建立以重组N蛋白为抗原的酶联免疫吸附测定(ELISA)法 ,并与以全病毒裂解液为抗原的ELISA法进行比较。结果 重组表达载体经诱导产生了高水平的重组融合N蛋白 ,融合蛋白经亲和纯化后 ,具备了较高的纯度和抗原反应性 ,以重组蛋白为抗原的ELISA法在特异性和敏感性方面优于以全病毒裂解液为抗原者。结论 重组SARS-CoV的N蛋白具有良好的抗原性和特异性 。 Objective To clone and express nucleocapsid (N) protein of the severe acute respiratory syndrome (SARS)-associated coronavirus, and to evaluate its antigenicity and application value in the development of serological diagnostic test for SARS. Methods SARS-associated coronavirus N protein gene was amplified from its genomic RNA by reverse transcript nested polymerase chain reaction (RT-nested-PCR) and cloned into pBAD/Thio-TOPO prokaryotic expression vector. The recombinant N fusion protein was expressed and purified,and its antigenicity and specificity was analyzed by Western Blot,to establish the recombinant N protein-based ELISA for detection of IgG antibodies to SARS-associated coronavirus,and SARS-associated coronavirus lysates-based ELISA was compared parallelly. Results The recombinant expression vector produced high level of the N fusion protein after induction,and that protein was purified successfully by affinity chromatography and displayed higher antigenicity and specificity as compared with whole virus lysates. Conclusion The recombinant SARS-associated coronavirus N protein possessed better antigenicity and specificity and could be employed to establish a new,sensitive,and specific ELISA for SARS diagnosis.
出处 《中华实验和临床病毒学杂志》 CAS CSCD 北大核心 2005年第1期64-67,共4页 Chinese Journal of Experimental and Clinical Virology
关键词 抗原性 SARS-CoV 临床应用研究 特异性 ELISA法 SARS冠状病毒 重组N蛋白 核衣壳蛋白 果重 呼吸综合征 Severe acute respiratory syndrome Coronaviridae Nucleocapsid proteins Gene expression Enzyme-linked immunosorbant assay
  • 相关文献

参考文献7

  • 1Ying W, Hao Y, Zhang Y, et al. Proteomic analysis on structural proteins of Severe Acute Respiratory. Syndrome coronavirus. Proteomies,2004, 4:492-504.
  • 2Krokhin O, Li Y, Andonov, A, et al. Mass Spectrometric Characterization of Proteins from the SARS Virus : A Preliminary Report.Mol Cell Proteomics, 2003, 2:346-356.
  • 3Rota PA, Oberste MS, Monroe SS, et al. Characterization of a novel coronavirus associated with severe acute respiratory syndrome. ,Science,2003, 300: 1394-1399.
  • 4Ruan Y J, Wei CL, Ee AL, et al. Comparative full-length genome sequence analysis of 14 SARS coronavirus isolates and common mutations associated with putative origins of infection. Laneet. 2003, 361 : 1779-1785.
  • 5汪运山 ,申红 ,孙善会 ,姜莉华 ,朱之炜 ,肖东杰 ,刘洋 ,黄平 ,杨博 ,杜希燕 ,张源潮 .自身免疫病患者血清中传染性非典型肺炎冠状病毒抗体阳性原因分析[J].中华检验医学杂志,2004,27(5):281-285. 被引量:5
  • 6Shi Y, Yi Y, Li P, et al. Diagnosis of severe acute respiratory syndrome(SARS) by detection of SARS coronavirus nucleocapsid antibodies in an antigen-capturing enzyme-linked immunosorbent assay, J Clin Microbiol,2003, 41:5781-5782.
  • 7Chen H, Wurm T, Britton P, et al. Interaction of the coronavirus nucleoprotein with nucleolar antigens and the host cell. J Virol, 2002,76 : 5233-5250.

二级参考文献13

  • 1From the Centers for Disease Control and Prevention. Severe Acute Respiratory Syndrome (SARS) and coronavirus testing-United States,2003. JAMA, 2003,289:2203-2206.
  • 2Booth CM, Matukas LM, Tomlinson GA, et al. Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area. JAMA, 2003,289:2801-2809.
  • 3From the Centers for Disease Control and Prevention. Update: Outbreak of severe acute respiratory syndrome-worldwide, 2003.Morb Mortal Wkly Rep, 2003,52:241-246,248.
  • 4Holmes KV. SARS coronavirus: a new challenge for prevention and therapy. J Clin Invest,2003,111:1605-1609.
  • 5World Health Organization Multicentre Collaborative Network for Severe Acute Respiratory Syndrome diagnosis. A multicentre collaboration to investigate the cause of severe acute respiratory syndrome. Lancet,2003, 361: 1730-1733.
  • 6Drosten C, Gunther S, Preiser W, et al. Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N Engl J Med, 2003,348:1967-1976.
  • 7Rota PA, Oberste MS,Monroe SS,et al. Characterization of a novel coronavirus associated with severe acute respiratory syndrome.Science, 2003,300:1394-1399.
  • 8Ksiazek TG, Erdman D, Goldsmith CS, et al. A novel coronavirus associated with severs acute respiratory syndrome. N Engl J Med,2003,348:1953-1966.
  • 9From the Centers for Disease Control and Prevention. Update:Severe Acute Respiratory Syndrome-United States,2003. Morb Mortal Wkly Rep, 2003,52:500-501.
  • 10From the Centers for Disease Control and Prevention. Update:Severe Acute Respiratory Syndrome-United States,2003. Morb Mortal Wkly Rep, 2003,52:357-360.

共引文献4

同被引文献5

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部